e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 52

Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis

Seulkee Lee; Seonyoung Kang; Yeonghee Eun; Hong‐Hee Won; Hyungjin Kim; Jaejoon Lee; Eun‐Mi Koh; Hoon‐Suk Cha · 2021 · Arthritis Research & Therapy

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: Few studies on rheumatoid arthritis (RA) have generated machine learning models to predict biologic disease-modifying antirheumatic drugs (bDMARDs) responses; however, these studies included insufficient analysis on important features. Moreover, machine learning is yet to be used to predict bDMARD responses in ankylosing spondylitis (AS). Thus, in this study, machine learning was used to predict such responses in RA and AS patients. METHODS: Data were retrieved from the Korean College of Rheumatology Biologics therapy (KOBIO) registry. The number of RA and AS patients in the traini

Abstract by Seulkee Lee; Seonyoung Kang; Yeonghee Eun; Hong‐Hee Won; Hyungjin Kim; Jaejoon Lee; Eun‐Mi Koh; Hoon‐Suk Cha, Arthritis Research & Therapy (2021) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1186/s13075-021-02635-3